Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nightingale Partners was a U.S.-based healthcare investment and advisory firm focused on social determinants of health and on connecting capital to payers and providers serving medically underserved populations. The company described itself as a Qualified Opportunity Zone fund and advisory platform, investing in and supporting healthcare services and healthcare SaaS businesses rather than developing therapeutics. Its work centered on Medicare Advantage, Medicaid, health equity, and non-clinical interventions intended to improve access and reduce avoidable healthcare spending. In June 2022, Nightingale Partners announced a strategic combination with NationsBenefits, after which the Nightingale team joined NationsBenefits to lead a newly formed corporate development group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nightingale Partners.